Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials

di Raji, Annaswamy, Long, Jianmin, Lam, Raymond L. H., O’Neill, Edward A., Engel, Samuel S.
Pubblicato in Diabetes Ther (2018)

Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency

di Raji, Annaswamy, Xu, Zhi Jin, Lam, Raymond L. H., O’Neill, Edward A., Kaufman, Keith D., Engel, Samuel S.
Pubblicato in Diabetes Ther (2020)

A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoS...

di Scott, Russell, Morgan, Jerry, Zimmer, Zachary, Lam, Raymond L. H., O'Neill, Edward A., Kaufman, Keith D., Engel, Samuel S., Raji, Annaswamy
Pubblicato in Diabetes Obes Metab (2018)

Double‐blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 d...

di Frias, Juan P., Zimmer, Zachary, Lam, Raymond L.H., Amorin, Guillermo, Ntabadde, Catherine, Iredale, Carol, O'Neill, Edward A., Engel, Samuel S., Kaufman, Keith D., Makimura, Hideo, Crutchlow, Michael F.
Pubblicato in Diabetes Obes Metab (2019)

Double‐blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin gl...

di Roussel, Ronan, Duran‐García, Santiago, Zhang, Yilong, Shah, Suneri, Darmiento, Carolyn, Shankar, R. Ravi, Golm, Gregory T., Lam, Raymond L. H., O'Neill, Edward A., Gantz, Ira, Kaufman, Keith D., Engel, Samuel S.
Pubblicato in Diabetes Obes Metab (2018)